|
Volumn 1, Issue 6, 2007, Pages 595-596
|
Modified Patient Stem Cells as Prelude to Autologous Treatment of Muscular Dystrophy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTISENSE OLIGONUCLEOTIDE;
CD133 ANTIGEN;
DYSTROPHIN;
LENTIVIRUS VECTOR;
AUTOLOGOUS STEM CELL TRANSPLANTATION;
CELL DIFFERENTIATION;
CELL FATE;
CELL ISOLATION;
CELL PROLIFERATION;
CELL SELECTION;
CELL SURVIVAL;
CLINICAL TRIAL;
DISEASE COURSE;
DNA MODIFICATION;
DUCHENNE MUSCULAR DYSTROPHY;
ENGRAFTMENT;
GRAFT REJECTION;
HEART DISEASE;
HEMATOPOIETIC STEM CELL;
HUMAN;
MYOBLAST;
NONHUMAN;
PATIENT SAFETY;
PLURIPOTENT STEM CELL;
PRIORITY JOURNAL;
PROTEIN SYNTHESIS;
SHORT SURVEY;
TISSUE REPAIR;
ANIMALS;
ANTIGENS, CD;
DISEASE MODELS, ANIMAL;
GLYCOPROTEINS;
HUMANS;
MICE;
MUSCULAR DYSTROPHIES;
PEPTIDES;
STEM CELL TRANSPLANTATION;
STEM CELLS;
TRANSDUCTION, GENETIC;
TRANSPLANTATION, AUTOLOGOUS;
TRANSPLANTATION, HETEROLOGOUS;
MUS;
|
EID: 36749026211
PISSN: 19345909
EISSN: None
Source Type: Journal
DOI: 10.1016/j.stem.2007.11.003 Document Type: Short Survey |
Times cited : (5)
|
References (10)
|